Sivelestat New Drug Therapy To Cure Liver Diseases

Sivelestat: New Drug Therapy To Cure Liver Diseases

Updated On:

Sivelestat: The researchers at Mayo Clinic have found a new drug therapy that can cure a fatal condition related to cirrhosis and other chronic liver diseases. The study was published in the journal Gastroenterology on March 11, 2019.

Cirrhosis is one of the acute liver diseases. It happens when cells in the liver are damaged and our body can no longer repair them. The disease, cirrhosis slows down the blood flow, which puts a restain on the portal vein. As a result, it causes portal hypertension also known as high blood pressure.

new_releases

Hirsutism: Symptoms, Causes, Diagnosis, And Treatment

Currently, there are therapies and treatments available to cure liver diseases such as hepatitis C and autoimmune hepatitis. However, when it comes to treating portal hypertension, there are limited options available in the market.

Symptoms for Cirrhosis of Liver

For this study, the research was conducted on a mouse model to check the drug sivelestat which may effectively lower the high blood pressure.

new_releases

TLIF: Remaining Conscious During Spine Surgery Can Fasten Recovery Of Patients

By using this drug, scientists were able to lower the high blood pressure by impeding the neutrophil (inflammatory cells). Neutrophils are responsible for the formation of fibrin, which are microvascular blood clots, that cause high blood pressure.

Thus, this drug proved to be effective in decreasing high blood pressure. It has also improved the symptoms and the overall result of those patients who were suffering from liver diseases.

Dr. Vijay Shah, the study author, and a Mayo Clinic gastroenterologist said, “This has been an interesting validation of our results and their human disease applicability. In patients with acute lung injury and bronchopulmonary dysplasia, sivelestat has been used securely.

Additionally, he said, “This indicates a potential means of decreasing of portal hypertension in patients with chronic liver disease because of sivelestat and comparable drugs.

new_releases

World Hepatitis Day: Could You Suffer And Not Know About Viral Hepatitis?

Stages of Cirrhosis of liver

Moira Hilscher, M.D., the paper’s first author, said, “Neutrophils had not previously been identified as significant drivers of portal hypertension. The research opens up the opportunity for new medicines to be developed and current compounds repurposed to target inflammation in the liver caused by mechanical forces related to disease.

She explained, “This is obviously an unmet need given the growing incidence of advanced liver disease owing to alcohol and obesity.

new_releases

Ovarian Cancer Cure By Unique New Class Of Drugs

According to the researchers, so far sivelestat has proved to be effective in humans for the treatment of acute lung injuries. Researchers have now claimed that it can also help in lowering blood pressure and might be able to cure patients who are suffering from chronic liver diseases.

Nonetheless, this drug therapy has opened new doors for further investigation specifically targeting the life-threatening liver diseases.

, , , , , , ,
Previous Post
Insomnia In Women: Causes, Symptoms And Treatment
Next Post
Sciatica Pain: 5 Natural Herbs To Relieve Pain Naturally

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.
You need to agree with the terms to proceed

Menu

Pin It on Pinterest